Drug Interaction Checkers Could Have Caught Adverse Events

FRIDAY, April 22, 2022 (HealthDay News) -- Use of drug interaction checkers could have identified several drug-drug interaction (DDI)-associated adverse drug reactions, including severe and life-threatening events among patients with COVID-19, according to a review published online April 19 in JAMA Network Open.
Valeria Conti, Ph.D., from University of Salerno in Italy, and colleagues conducted a systematic literature review to identify DDIs that led to adverse clinical outcomes and/or adverse drug reactions in patients with COVID-19.
The researchers identified DDIs involving 46 different drugs, with 575 DDIs for 58 drug pairs (305 associated with at least one adverse drug reaction) reported. Lopinavir and ritonavir were the drugs most involved in DDIs. Twenty included studies (enrolled 1,297 patients) reported 115 DDI-related adverse events, of which 26 percent were identifiable by all tools analyzed, 50 percent were identifiable by at least one drug interaction checker, and 24 percent remained nonidentifiable.
"Notwithstanding the emergency context of the COVID-19 pandemic, DDI-related adverse events should never be overlooked to customize the most effective and safest therapy," the authors write.
One author disclosed financial ties to the pharmaceutical industry.
Related Posts
Survival Inferior in Black Patients With Acute Myeloid Leukemia
WEDNESDAY, March 23, 2022 (HealthDay News) -- For patients with acute myeloid...
Intensive Inpatient BP Management Not Beneficial in Seniors
WEDNESDAY, June 21, 2023 (HealthDay News) -- For hospitalized older adults with...
Medicare Eligibility Linked to Improvements in Health Care Access
TUESDAY, Oct. 4, 2022 (HealthDay News) -- Medicare eligibility and enrollment at...
Many Seniors Love Pickleball, But Injuries Can Happen
SATURDAY, Aug. 6, 2022 (HealthDay News) -- Pickleball has become a wildly...